<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>As filed with the Securities and Exchange Commission
on June&nbsp;20, 2025</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin: 0pt 0; text-indent: 413pt"><B>Registration No.&nbsp;333-</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0; margin-bottom: 0; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNITED STATES</B></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Washington, D.C. 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></P>

<P STYLE="border-top: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FORM&nbsp;S-8</B></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>REGISTRATION STATEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><I>UNDER</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><I>THE SECURITIES ACT OF 1933</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></P>

<P STYLE="border-top: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></P>

<P STYLE="font: 24pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>MIND MEDICINE (MINDMED) INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Exact name of registrant as specified in its
charter)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></P>

<P STYLE="border-top: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR>
<TD STYLE="text-align: center; width: 49%"><B>British Columbia, Canada<BR> </B>(State or other jurisdiction of<BR> incorporation or organization)</TD>
<TD STYLE="text-align: center; width: 2%">&nbsp;</TD>
<TD STYLE="text-align: center; width: 49%"><B>98-1582438<BR> </B>(I.R.S. Employer<BR> Identification Number)</TD></TR>
<TR>
<TD STYLE="text-align: center">&nbsp;</TD>
<TD STYLE="text-align: center">&nbsp;</TD>
<TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR>
<TD STYLE="text-align: center"><B>One World Trade Center, Suite&nbsp;8500<BR> New York, New York<BR> (212) 220-6633</B> <BR>
(Address of Principal Executive Offices)</TD>
<TD STYLE="text-align: center">&nbsp;</TD>
<TD STYLE="text-align: center"><B>10007<BR> </B>(Zip Code)</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>MIND MEDICINE (MINDMED) INC. 2025 EQUITY
INCENTIVE PLAN</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>MIND MEDICINE (MINDMED) INC. PERFORMANCE AND
RESTRICTED SHARE UNIT PLAN</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>INDIVIDUAL NONSTATUTORY STOCK OPTION AWARDS
(INDUCEMENT GRANTS)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>INDIVIDUAL RESTRICTED SHARE UNIT AWARDS (INDUCEMENT
GRANTS)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>INDIVIDUAL PERFORMANCE SHARE UNIT AWARDS (INDUCEMENT
GRANTS)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Full titles of the plans)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></P>

<P STYLE="border-top: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Mark Sullivan</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Chief Legal Officer</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Mind Medicine (MindMed) Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>One World Trade Center</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Suite&nbsp;8500</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>New York, New York 10007</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Name and address of agent for service)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(212) 220-6633</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Telephone number, including area code, of agent
for service)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></P>

<P STYLE="border-top: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><I>Copies to:</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR>
<TD STYLE="text-align: center; vertical-align: top; width: 49%"><B>Steven J. Abrams<BR> Hogan Lovells US LLP<BR> 1735 Market Street<BR> Suite&nbsp;2300<BR> Philadelphia, Pennsylvania 19103<BR> (267) 675-4600</B></TD>
<TD STYLE="text-align: center; vertical-align: bottom; font-size: 10pt; width: 2%">&nbsp;</TD>
<TD STYLE="text-align: center; vertical-align: top; width: 49%"><B>Trevor Scott<BR> Minji Park<BR> Osler, Hoskin&nbsp;&amp; Harcourt LLP<BR> Suite&nbsp;3000, Bentall Four<BR> 1055 Dunsmuir Street<BR> Vancouver, British Columbia, Canada V7X 1K8<BR> (778) 785-3000</B></TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Indicate by check mark whether the registrant is a large accelerated
filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of
 &ldquo;large accelerated filer,&rdquo; &ldquo;accelerated filer,&rdquo; &ldquo;smaller reporting company&rdquo; and &ldquo;emerging growth
company&rdquo; in Rule&nbsp;12b-2 of the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Large&nbsp;accelerated&nbsp;filer</FONT></TD>
    <TD STYLE="font-size: 10pt; width: 4%"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD>
    <TD STYLE="font-size: 10pt; width: 2%">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accelerated&nbsp;filer</FONT></TD>
    <TD STYLE="font-size: 10pt; width: 4%"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-accelerated filer</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Wingdings">&#120;</FONT></TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Smaller&nbsp;reporting&nbsp;company</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Wingdings">&#120;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging&nbsp;growth&nbsp;company</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="font-family: Wingdings">&#120;</FONT></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If an emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant
to Section&nbsp;7(a)(2)(B)&nbsp;of the Securities Act. <FONT STYLE="font-family: Wingdings">&#168;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0; margin-bottom: 0; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXPLANATORY NOTE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><B>Mind Medicine (MindMed) Inc. 2025 Equity Incentive
Plan</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">This registration statement
on Form&nbsp;S-8 (this &ldquo;<B><I>Registration Statement</I></B>&rdquo;) is being filed by Mind Medicine (MindMed) Inc. (the &ldquo;<B><I>Registrant</I></B>&rdquo;),
to register an aggregate of 13,818,090 common shares, no par value per share, of the Registrant (the &ldquo;<B><I>Common Shares</I></B>&rdquo;),
issuable under the Mind Medicine (MindMed) Inc. 2025 Equity Incentive Plan (the &ldquo;<B><I>2025 Plan</I></B>&rdquo;), consisting of
(a)&nbsp;4,500,000 Common Shares reserved for issuance under the 2025 Plan, and (b)&nbsp;a maximum of 9,318,090 Common Shares (the &ldquo;<B><I>Outstanding
Award Shares</I></B>&rdquo;) consisting of (i)&nbsp;an aggregate of 3,500,979 Common Shares that were subject to outstanding option awards
under the Mind Medicine (MindMed) Inc. Stock Option Plan, as amended (the &ldquo;<B><I>Option Plan</I></B>&rdquo;), and (ii)&nbsp;an aggregate
of 5,817,111 Common Shares subject to outstanding restricted share unit awards and performance share unit awards under the Mind Medicine
(MindMed) Inc. Performance and Restricted Share Unit Plan, as amended (the &ldquo;<B><I>PRSU Plan</I></B>&rdquo; and, together with the
Option Plan, the &ldquo;<B><I>Prior Plans</I></B>&rdquo;), as of March&nbsp;14, 2025, the date the Prior Plans were retired. Pursuant
to Section&nbsp;4.1 of the 2025 Plan, the Outstanding Award Shares will become available for issuance under the 2025 Plan if such awards
under the Prior Plans are forfeited or otherwise terminated. The Board of Directors of the Registrant approved the 2025 Plan on April&nbsp;22,
2025, and the Registrant&rsquo;s shareholders approved the 2025 Plan at the Registrant&rsquo;s 2025 Annual General and Special Meeting
of Shareholders on June&nbsp;12, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><B>Mind Medicine (MindMed)
Inc. Performance and Restricted Share Unit Plan</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">This Registration Statement
is also being filed to register 147,133 Common Shares, issuable under the PRSU Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><B>Inducement Grants</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">This Registration Statement
is also being filed to register an aggregate of 2,402,550 Common Shares issuable upon the exercise of individual nonqualified stock option
awards and upon vesting and settlement of restricted share units and performance share units granted to employees of the Registrant as
an inducement material to entry into employment with the Registrant, in accordance with Nasdaq Listing Rule&nbsp;5635(c)(4).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PART&nbsp;I</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>INFORMATION REQUIRED IN THE SECTION&nbsp;10(A)&nbsp;PROSPECTUS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">As permitted by the rules&nbsp;of
the Securities and Exchange Commission (the &ldquo;<B><I>Commission</I></B>&rdquo;), the information specified in Part&nbsp;I of Form&nbsp;S-8
is omitted from this Registration Statement. The documents containing the information specified in Part&nbsp;I of Form&nbsp;S-8 will be
delivered to the participants in the plans covered by this Registration Statement as required by Rule&nbsp;428(b)(1)&nbsp;under the Securities
Act of 1933, as amended (the &ldquo;<B><I>Securities Act</I></B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PART&nbsp;II</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>INFORMATION REQUIRED IN THE REGISTRATION STATEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 10%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ITEM&nbsp;3.</B></FONT></TD>
    <TD STYLE="font-size: 10pt; width: 90%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>INCORPORATION OF DOCUMENTS BY REFERENCE </B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The following documents filed
by the Registrant with the Commission are incorporated by reference into this Registration Statement:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">a)</TD><TD STYLE="text-align: justify">The Registrant&rsquo;s Annual Report
                                            on <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1813814/000095017025034176/mnmd-20241231.htm" STYLE="-sec-extract: exhibit">Form&nbsp;10-K</A> for the fiscal year ended December&nbsp;31, 2024, filed with the Commission
                                            on March&nbsp;6, 2025, including portions of the Registrant&rsquo;s Definitive Proxy Statement
                                            on <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1813814/000110465925038010/tm252609-1_def14a.htm" STYLE="-sec-extract: exhibit">Schedule 14A</A>, filed with the Commission on April&nbsp;23, 2025, that are incorporated
                                            by reference into Part&nbsp;III of such Annual Report on Form&nbsp;10-K;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">b)</TD><TD STYLE="text-align: justify">The Registrant&rsquo;s Quarterly Report
                                            on <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1813814/000095017025066387/mnmd-20250331.htm" STYLE="-sec-extract: exhibit">Form&nbsp;10-Q</A> for the quarterly period ended March&nbsp;31, 2025, filed with the Commission
                                            on May&nbsp;8, 2025;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">c)</TD><TD STYLE="text-align: justify">The Registrant&rsquo;s Current Reports on Form&nbsp;8-K (other than portions thereof furnished under Item
2.02 or Item 7.01 of Form&nbsp;8-K and exhibits accompanying such reports that relate to such items), filed with the Commission on <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1813814/000110465925002868/tm253011d1_8k.htm" STYLE="-sec-extract: exhibit">January&nbsp;13, 2025</A>, <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1813814/000095017025010802/mnmd-20250130.htm" STYLE="-sec-extract: exhibit">January&nbsp;30, 2025</A>, <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1813814/000095017025053953/mnmd-20250415.htm" STYLE="-sec-extract: exhibit">April&nbsp;15, 2025</A>, <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1813814/000110465925036841/tm2512703d1_8k.htm" STYLE="-sec-extract: exhibit">April&nbsp;21, 2025</A>, <A HREF="https://www.sec.gov/ix?doc=/Archives/edgar/data/1813814/000110465925052719/tm2516110d1_8k.htm" STYLE="-sec-extract: exhibit">May&nbsp;27, 2025</A> and <A HREF="https://www.sec.gov/Archives/edgar/data/1813814/000095017025086830/mnmd-20250616.htm" STYLE="-sec-extract: exhibit">June&nbsp;16, 2025</A>; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">d)</TD><TD STYLE="text-align: justify">The description of the Registrant&rsquo;s common shares which is contained in the Registrant&rsquo;s Registration
Statement on <FONT><A HREF="https://www.sec.gov/Archives/edgar/data/1813814/000110465921053876/tm2112540d1_8a12b.htm" STYLE="-sec-extract: exhibit">Form&nbsp;8-A</A></FONT>, filed with the Commission on April&nbsp;22, 2021 (File No 001-40360) under
the Securities Exchange Act of 1934, as amended (the &ldquo;<B><I>Exchange Act</I></B>&rdquo;), as updated by <FONT><A HREF="https://www.sec.gov/Archives/edgar/data/1813814/000095017025034176/mnmd-ex4_1.htm" STYLE="-sec-extract: exhibit">Exhibit&nbsp;4.1</A></FONT>&nbsp;to
the Registrant&rsquo;s Annual Report on Form&nbsp;10-K&nbsp;for the fiscal year ended December&nbsp;31, 2024, filed with the Commission
on March&nbsp;6, 2025, including any amendment or report filed for the purpose of updating such description.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">All documents subsequently
filed by the Registrant pursuant to Sections 13(a), 13(c), 14 or 15(d)&nbsp;of the Exchange Act after the date of this Registration Statement
and prior to the filing of a post-effective amendment to this Registration Statement which indicates that all securities offered have
been sold or which deregisters all securities then remaining unsold, shall be deemed to be incorporated by reference into this Registration
Statement and to be part hereof from the date of filing of such documents; provided, however, that documents or portions thereof that
are furnished and not filed in accordance with the rules&nbsp;of the Commission shall not be deemed incorporated by reference into this
Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Any statement in a document
incorporated or deemed to be incorporated by reference into this Registration Statement shall be deemed to be modified or superseded for
purposes of this Registration Statement to the extent that a statement contained in this Registration Statement or in any other later
filed document that also is or is deemed to be incorporated by reference into this Registration Statement modifies or supersedes such
statement. Any such statement so modified or superseded shall not be deemed, except as so modified or superseded, to be a part of this
Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 10%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ITEM&nbsp;4.</B></FONT></TD>
    <TD STYLE="width: 90%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>DESCRIPTION OF SECURITIES </B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Not applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 10%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ITEM&nbsp;5.</B></FONT></TD>
    <TD STYLE="width: 90%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>INTERESTS OF NAMED EXPERTS AND COUNSEL </B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Not applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 10%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ITEM&nbsp;6.</B></FONT></TD>
    <TD STYLE="width: 90%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>INDEMNIFICATION OF DIRECTORS AND OFFICERS</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Registrant is subject
to the provisions of Part&nbsp;5, Division 5 of the Business Corporations Act (<I>British Columbia</I>) (the &ldquo;<B><I>Act</I></B>&rdquo;),
and the indemnification provisions set forth in the Registrant&rsquo;s amended and restated articles (the &ldquo;<B><I>Articles</I></B>&rdquo;).
The Registrant has also entered into indemnity agreements with each of its directors and executive officers which provide its directors
and executive officers with contractual rights to indemnification and, in some cases, expenses advancement in any action or proceedings
arising out of their services as one of its directors or executive officers or as a director or executive officer of any other company
or enterprise to which the person provides services at the Registrant&rsquo;s request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Under the Registrant&rsquo;s
Articles and Section&nbsp;160 of the Act, subject to Section&nbsp;163 of the Act, the Registrant may:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">a)</TD><TD STYLE="text-align: justify">indemnify an individual who:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="text-align: right; width: 0.15in">i.</TD>
    <TD STYLE="width: 0.25in">&nbsp;</TD><TD STYLE="text-align: justify">is or was a director or officer of the Registrant,</TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD></TD><TD STYLE="text-align: right">ii.</TD>
    <TD>&nbsp;</TD><TD STYLE="text-align: justify">is or was a director or officer of another corporation (A)&nbsp;at a time when such corporation is or
was an affiliate of the Registrant; or (B)&nbsp;at the Registrant&rsquo;s request, or</TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD></TD><TD STYLE="text-align: right">iii.</TD>
    <TD>&nbsp;</TD><TD STYLE="text-align: justify">at the Registrant&rsquo;s request, is or was, or holds or held a position equivalent to that of, a director
or officer of a partnership, trust, joint venture or other unincorporated entity,</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">including, subject to certain limited
exceptions, the heirs and personal or other legal representatives of that individual (collectively, an &ldquo;<B><I>eligible party</I></B>&rdquo;),
against all eligible penalties, as defined below, to which the eligible party is or may be liable; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">b)</TD><TD STYLE="text-align: justify">after final disposition of an eligible proceeding, pay the expenses actually and reasonably incurred by
an eligible party in respect of that proceeding, where:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="white-space: nowrap; text-align: right; width: 0.15in">i.</TD>
    <TD STYLE="width: 0.25in">&nbsp;</TD><TD STYLE="text-align: justify">&ldquo;<B><I>eligible penalty</I></B>&rdquo; means a judgment, penalty or fine awarded or imposed in,
or an amount paid in settlement of, an eligible proceeding,</TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD STYLE="white-space: nowrap; text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD></TD><TD STYLE="white-space: nowrap; text-align: right">ii.</TD>
    <TD>&nbsp;</TD><TD STYLE="text-align: justify">&ldquo;<B><I>eligible proceeding</I></B>&rdquo; means a proceeding in which an eligible party or any of
the heirs and personal or other legal representatives of the eligible party, by reason of the eligible party being or having been a director
or officer of, or holding or having held a position equivalent to that of a director or officer of, the Registrant or an associated corporation
(A)&nbsp;is or may be joined as a party, or (B)&nbsp;is or may be liable for or in respect of a judgment, penalty or fine in, or expenses
related to, the proceeding,</TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD STYLE="white-space: nowrap; text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD></TD><TD STYLE="white-space: nowrap; text-align: right">iii.</TD>
    <TD>&nbsp;</TD><TD STYLE="text-align: justify">&ldquo;<B><I>expenses</I></B>&rdquo; includes costs, charges and expenses, including legal and other fees,
but does not include judgments, penalties, fines or amounts paid in settlement of a proceeding, and</TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD STYLE="white-space: nowrap; text-align: right">&nbsp;</TD>
    <TD>&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD></TD><TD STYLE="white-space: nowrap; text-align: right">iv.</TD>
    <TD>&nbsp;</TD><TD STYLE="text-align: justify">&ldquo;<B><I>proceeding</I></B>&rdquo; includes any legal proceeding or investigative action, whether
current, threatened, pending or completed.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Under the Registrant&rsquo;s
Articles, the Registrant may also indemnify any employee, agent or representative of the Registrant, subject to any restrictions under
the Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Under the Registrant&rsquo;s
Articles and Section&nbsp;161 of the Act, and subject to Section&nbsp;163 of the Act, the Registrant must, after the final disposition
of an eligible proceeding, pay the expenses actually and reasonably incurred by an eligible party in respect of that proceeding if the
eligible party (a)&nbsp;has not been reimbursed for those expenses, and (b)&nbsp;is wholly successful, on the merits or otherwise, in
the outcome of the proceeding or is substantially successful on the merits in the outcome of the proceeding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Under Section&nbsp;162 of
the Act, and subject to Section&nbsp;163 of the Act, the Registrant may pay, as they are incurred in advance of the final disposition
of an eligible proceeding, the expenses actually and reasonably incurred by an eligible party in respect of the proceeding, provided that
the Registrant must not make such payments unless the Registrant first receives from the eligible party a written undertaking that, if
it is ultimately determined that the payment of expenses is prohibited under Section&nbsp;163 of the Act, the eligible party will repay
the amounts advanced.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Under Section&nbsp;163 of
the Act, the Registrant must not indemnify an eligible party against eligible penalties to which the eligible party is or may be liable
or pay the expenses of an eligible party in respect of that proceeding under Sections&nbsp;160, 161 or 162 of the Act, as the case may
be, if any of the following circumstances apply:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">a)</TD><TD STYLE="text-align: justify">if the indemnity or payment is made under an earlier agreement to indemnify or pay expenses and, at the
time that the agreement to indemnify or pay expenses was made, the Registrant was prohibited from giving the indemnity or paying the expenses
by the Registrant&rsquo;s memorandum or articles;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">b)</TD><TD STYLE="text-align: justify">if the indemnity or payment is made otherwise than under an earlier agreement to indemnify or pay expenses
and, at the time that the indemnity or payment is made, the Registrant is prohibited from giving the indemnity or paying the expenses
by the Registrant&rsquo;s memorandum or articles;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">c)</TD><TD STYLE="text-align: justify">if, in relation to the subject matter of the eligible proceeding, the eligible party did not act honestly
and in good faith with a view to the best interests of the Registrant or the associated corporation, as the case may be; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">d)</TD><TD STYLE="text-align: justify">in the case of an eligible proceeding other than a civil proceeding, if the eligible party did not have
reasonable grounds for believing that the eligible party&rsquo;s conduct in respect of which the proceeding was brought was lawful.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">If an eligible proceeding
is brought against an eligible party by or on behalf of the Registrant or by or on behalf of an associated corporation, the Registrant
must not either indemnify the eligible party under Section&nbsp;160(a)&nbsp;of the Act against eligible penalties to which the eligible
party is or may be liable, or pay the expenses of the eligible party under Sections&nbsp;160(b), 161 or 162 of the Act, as the case may
be, in respect of the proceeding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Under Section&nbsp;164 of
the Act, and despite any other provision of Part&nbsp;5, Division 5 of the Act and whether or not payment of expenses or indemnification
has been sought, authorized or declined under Part&nbsp;5, Division 5 of the Act, on application of the Registrant or an eligible party,
the court may do one or more of the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">a)</TD><TD STYLE="text-align: justify">order the Registrant to indemnify an eligible party against any liability incurred by the eligible party
in respect of an eligible proceeding;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">b)</TD><TD STYLE="text-align: justify">order the Registrant to pay some or all of the expenses incurred by an eligible party in respect of an
eligible proceeding;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">c)</TD><TD STYLE="text-align: justify">order the enforcement of, or any payment under, an agreement of indemnification entered into by the Registrant;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">d)</TD><TD STYLE="text-align: justify">order the Registrant to pay some or all of the expenses actually and reasonably incurred by any person
in obtaining an order under Section&nbsp;164 of the Act; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">e)</TD><TD STYLE="text-align: justify">make any other order the court considers appropriate.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Section&nbsp;165 of the Act
provides that the Registrant may purchase and maintain insurance for the benefit of an eligible party or the heirs and personal or other
legal representatives of the eligible party against any liability that may be incurred by reason of the eligible party being or having
been a director or officer of, or holding or having held a position equivalent to that of a director or officer of, the Registrant or
an associated corporation. Under the Registrant&rsquo;s Articles, the Registrant may also purchase and maintain insurance for the benefit
of any person (or his or her heirs or legal personal representatives) who:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">a)</TD><TD STYLE="text-align: justify">is or was a director, officer, employee or agent of the Registrant;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">b)</TD><TD STYLE="text-align: justify">is or was a director, officer, employee or agent of another corporation at a time when such corporation
is or was an affiliate of the Registrant;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">c)</TD><TD STYLE="text-align: justify">at the Registrant&rsquo;s request, is or was, a director, officer, employee or agent of a corporation
or of a partnership, trust, joint venture or other unincorporated entity; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">d)</TD><TD STYLE="text-align: justify">at the Registrant&rsquo;s request, holds or held a position equivalent to that of, a director or officer
of a partnership, trust, joint venture or other unincorporated entity,</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">against any liability incurred
by him or her as such director, officer, employee or agent or person who holds or held such equivalent position.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Registrant maintains
directors&rsquo; and officers&rsquo; liability insurance which insures directors and officers for losses as a result of claims against
the directors and officers of the Registrant in their capacity as directors and officers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Pursuant to the Registrant&rsquo;s
Articles, the failure of a director or officer of the Registrant to comply with the Act or the Registrant&rsquo;s Articles does not invalidate
any indemnity to which he or she is entitled under the Registrant&rsquo;s Articles.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Insofar as indemnification
for liabilities arising under the Securities Act may be permitted to directors, officers or persons controlling the Registrant pursuant
to the foregoing provisions, the Registrant has been informed that in the opinion of the Commission such indemnification is against public
policy as expressed in the Securities Act and is therefore unenforceable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 10%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ITEM&nbsp;7.</B></FONT></TD>
    <TD STYLE="width: 90%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXEMPTION FROM REGISTRATION CLAIMED </B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Not applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 10%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ITEM&nbsp;8.</B></FONT></TD>
    <TD STYLE="width: 90%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBITS </B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
<TD STYLE="text-align: center; width: 8%"><B>Exhibit</B> <B>Number</B></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
<TD STYLE="text-align: center; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Description</B></FONT></TD>
<TD STYLE="text-align: center; width: 10%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Form</B></FONT></TD>
<TD STYLE="text-align: center; width: 10%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit&nbsp;No.</B></FONT></TD>
<TD STYLE="text-align: center; width: 15%"><B>Incorporated&nbsp;by<BR> Reference Filing<BR> Date</B></TD>
<TD STYLE="text-align: center; width: 10%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>File No.</B></FONT></TD></TR>
<TR>
<TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
<TD>&nbsp;</TD>
<TD>&nbsp;</TD>
<TD>&nbsp;</TD>
<TD STYLE="text-align: center">&nbsp;</TD>
<TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR>
<TD STYLE="white-space: nowrap; vertical-align: top"><A HREF="https://www.sec.gov/Archives/edgar/data/1813814/000119312522186293/d730734dex31.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</FONT></A></TD>
    <TD>&nbsp;</TD>
<TD STYLE="vertical-align: top"><A HREF="https://www.sec.gov/Archives/edgar/data/1813814/000119312522186293/d730734dex31.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amended and Restated Articles of Mind Medicine (MindMed) Inc., effective as of June&nbsp;30, 2022. </FONT></A></TD>
<TD STYLE="vertical-align: bottom; text-align: right"><A HREF="https://www.sec.gov/Archives/edgar/data/1813814/000119312522186293/d730734dex31.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></A></TD>
<TD STYLE="vertical-align: bottom; text-align: right"><A HREF="https://www.sec.gov/Archives/edgar/data/1813814/000119312522186293/d730734dex31.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</FONT></A></TD>
<TD STYLE="text-align: center; vertical-align: bottom"><A HREF="https://www.sec.gov/Archives/edgar/data/1813814/000119312522186293/d730734dex31.htm" STYLE="-sec-extract: exhibit">June&nbsp;30, 2022</A></TD>
<TD STYLE="vertical-align: bottom; text-align: center"><A HREF="https://www.sec.gov/Archives/edgar/data/1813814/000119312522186293/d730734dex31.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">001-40360</FONT></A></TD></TR>
<TR>
<TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
<TD>&nbsp;</TD>
<TD>&nbsp;</TD>
<TD>&nbsp;</TD>
<TD STYLE="text-align: center">&nbsp;</TD>
<TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR>
<TD STYLE="white-space: nowrap; vertical-align: top"><A HREF="https://www.sec.gov/Archives/edgar/data/1813814/000095017024095753/mnmd-ex3_2.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2</FONT></A></TD>
    <TD>&nbsp;</TD>
<TD STYLE="vertical-align: top"><A HREF="https://www.sec.gov/Archives/edgar/data/1813814/000095017024095753/mnmd-ex3_2.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notice of Articles,&nbsp;Incorporated on July&nbsp;26, 2010, as altered on July&nbsp;30, 2024.</FONT></A></TD>
<TD STYLE="vertical-align: bottom; text-align: right"><A HREF="https://www.sec.gov/Archives/edgar/data/1813814/000095017024095753/mnmd-ex3_2.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10-Q</FONT></A></TD>
<TD STYLE="vertical-align: bottom; text-align: right"><A HREF="https://www.sec.gov/Archives/edgar/data/1813814/000095017024095753/mnmd-ex3_2.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2</FONT></A></TD>
<TD STYLE="text-align: center; vertical-align: bottom"><A HREF="https://www.sec.gov/Archives/edgar/data/1813814/000095017024095753/mnmd-ex3_2.htm" STYLE="-sec-extract: exhibit">August&nbsp;13, 2024</A></TD>
<TD STYLE="vertical-align: bottom; text-align: center"><A HREF="https://www.sec.gov/Archives/edgar/data/1813814/000095017024095753/mnmd-ex3_2.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">001-40360</FONT></A></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR>
<TD STYLE="white-space: nowrap; vertical-align: top; width: 8%"><A HREF="https://www.sec.gov/Archives/edgar/data/1813814/000095017024021656/mnmd-ex4_2.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3</FONT></A></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
<TD STYLE="vertical-align: top; width: 45%"><A HREF="https://www.sec.gov/Archives/edgar/data/1813814/000095017024021656/mnmd-ex4_2.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form&nbsp;of
Mind Medicine (MindMed) Inc. Common Share Certificate.</FONT></A></TD>
<TD STYLE="vertical-align: bottom; text-align: right; width: 10%"><A HREF="https://www.sec.gov/Archives/edgar/data/1813814/000095017024021656/mnmd-ex4_2.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10-K</FONT></A></TD>
<TD STYLE="vertical-align: bottom; text-align: right; width: 10%"><A HREF="https://www.sec.gov/Archives/edgar/data/1813814/000095017024021656/mnmd-ex4_2.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2</FONT></A></TD>
<TD STYLE="text-align: center; vertical-align: bottom; width: 15%"><A HREF="https://www.sec.gov/Archives/edgar/data/1813814/000095017024021656/mnmd-ex4_2.htm" STYLE="-sec-extract: exhibit">February&nbsp;28,
2024</A></TD>
<TD STYLE="vertical-align: bottom; text-align: center; width: 10%"><A HREF="https://www.sec.gov/Archives/edgar/data/1813814/000095017024021656/mnmd-ex4_2.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">001-40360</FONT></A></TD></TR>
<TR>
<TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
<TD>&nbsp;</TD>
<TD STYLE="text-align: right">&nbsp;</TD>
<TD STYLE="text-align: right">&nbsp;</TD>
<TD STYLE="text-align: center">&nbsp;</TD>
<TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR>
<TD STYLE="white-space: nowrap; vertical-align: top"><A HREF="tm2518234d1_ex5-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1*</FONT></A></TD>
    <TD>&nbsp;</TD>
<TD STYLE="vertical-align: top"><A HREF="tm2518234d1_ex5-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Opinion of Osler, Hoskin&nbsp;&amp;
Harcourt LLP.</FONT></A></TD>
<TD STYLE="text-align: right; vertical-align: bottom">&nbsp;</TD>
<TD STYLE="text-align: right; vertical-align: bottom">&nbsp;</TD>
<TD STYLE="text-align: center; vertical-align: bottom">&nbsp;</TD>
<TD STYLE="text-align: center; vertical-align: bottom">&nbsp;</TD></TR>
<TR>
<TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
<TD>&nbsp;</TD>
<TD STYLE="text-align: right">&nbsp;</TD>
<TD STYLE="text-align: right">&nbsp;</TD>
<TD STYLE="text-align: center">&nbsp;</TD>
<TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR>
<TD STYLE="white-space: nowrap; vertical-align: top"><A HREF="tm2518234d1_ex23-1.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.1*</FONT></A></TD>
    <TD>&nbsp;</TD>
<TD STYLE="vertical-align: top"><A HREF="tm2518234d1_ex23-1.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consent
of KPMG LLP.</FONT></A></TD>
<TD STYLE="text-align: right; vertical-align: bottom">&nbsp;</TD>
<TD STYLE="text-align: right; vertical-align: bottom">&nbsp;</TD>
<TD STYLE="text-align: center; vertical-align: bottom">&nbsp;</TD>
<TD STYLE="text-align: center; vertical-align: bottom">&nbsp;</TD></TR>
<TR>
<TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
<TD>&nbsp;</TD>
<TD STYLE="text-align: right">&nbsp;</TD>
<TD STYLE="text-align: right">&nbsp;</TD>
<TD STYLE="text-align: center">&nbsp;</TD>
<TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR>
<TD STYLE="white-space: nowrap; vertical-align: top"><A HREF="tm2518234d1_ex5-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.2*</FONT></A></TD>
    <TD>&nbsp;</TD>
<TD STYLE="vertical-align: top"><A HREF="tm2518234d1_ex5-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consent of Osler, Hoskin&nbsp;&amp;
Harcourt LLP (included in Exhibit&nbsp;5.1).</FONT></A></TD>
<TD STYLE="text-align: right; vertical-align: bottom">&nbsp;</TD>
<TD STYLE="text-align: right; vertical-align: bottom">&nbsp;</TD>
<TD STYLE="text-align: center; vertical-align: bottom">&nbsp;</TD>
<TD STYLE="text-align: center; vertical-align: bottom">&nbsp;</TD></TR>
<TR>
<TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
<TD>&nbsp;</TD>
<TD STYLE="text-align: right">&nbsp;</TD>
<TD STYLE="text-align: right">&nbsp;</TD>
<TD STYLE="text-align: center">&nbsp;</TD>
<TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR>
<TD STYLE="white-space: nowrap; vertical-align: top"><A HREF="#a_001" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24.1*</FONT></A></TD>
    <TD>&nbsp;</TD>
<TD STYLE="vertical-align: top"><A HREF="#a_001" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Powers of Attorney (included
on the signature page). </FONT></A></TD>
<TD STYLE="text-align: right; vertical-align: bottom">&nbsp;</TD>
<TD STYLE="text-align: right; vertical-align: bottom">&nbsp;</TD>
<TD STYLE="text-align: center; vertical-align: bottom">&nbsp;</TD>
<TD STYLE="text-align: center; vertical-align: bottom">&nbsp;</TD></TR>
<TR>
<TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
<TD>&nbsp;</TD>
<TD STYLE="text-align: right">&nbsp;</TD>
<TD STYLE="text-align: right">&nbsp;</TD>
<TD STYLE="text-align: center">&nbsp;</TD>
<TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR>
<TD STYLE="white-space: nowrap; vertical-align: top"><A HREF="https://www.sec.gov/Archives/edgar/data/1813814/000095017025086830/mnmd-ex10_1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</FONT></A></TD>
    <TD>&nbsp;</TD>
<TD STYLE="vertical-align: top"><A HREF="https://www.sec.gov/Archives/edgar/data/1813814/000095017025086830/mnmd-ex10_1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mind
Medicine (MindMed) Inc. 2025 Equity Incentive Plan.</FONT></A></TD>
<TD STYLE="vertical-align: bottom; text-align: right"><A HREF="https://www.sec.gov/Archives/edgar/data/1813814/000095017025086830/mnmd-ex10_1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></A></TD>
<TD STYLE="vertical-align: bottom; text-align: right"><A HREF="https://www.sec.gov/Archives/edgar/data/1813814/000095017025086830/mnmd-ex10_1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</FONT></A></TD>
<TD STYLE="text-align: center; vertical-align: bottom"><A HREF="https://www.sec.gov/Archives/edgar/data/1813814/000095017025086830/mnmd-ex10_1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">June&nbsp;16,
2025</FONT></A></TD>
<TD STYLE="vertical-align: bottom; text-align: center"><A HREF="https://www.sec.gov/Archives/edgar/data/1813814/000095017025086830/mnmd-ex10_1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">001-40360</FONT></A></TD></TR>
<TR>
<TD STYLE="white-space: nowrap; vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD>
<TD STYLE="vertical-align: top">&nbsp;</TD>
<TD STYLE="vertical-align: bottom; text-align: right">&nbsp;</TD>
<TD STYLE="vertical-align: bottom; text-align: right">&nbsp;</TD>
<TD STYLE="text-align: center; vertical-align: bottom">&nbsp;</TD>
<TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
<TR>
<TD STYLE="white-space: nowrap; vertical-align: top"><A HREF="tm2518234d1_ex99-2.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.2*</FONT></A></TD>
    <TD>&nbsp;</TD>
<TD STYLE="vertical-align: top"><A HREF="tm2518234d1_ex99-2.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form&nbsp;of
Stock Option Award Agreement to Mind Medicine (MindMed) Inc. 2025 Equity Incentive Plan.</FONT></A></TD>
<TD STYLE="vertical-align: bottom; text-align: right">&nbsp;</TD>
<TD STYLE="vertical-align: bottom; text-align: right">&nbsp;</TD>
<TD STYLE="text-align: center; vertical-align: bottom">&nbsp;</TD>
<TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
<TR>
<TD STYLE="white-space: nowrap; vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD>
<TD STYLE="vertical-align: top">&nbsp;</TD>
<TD STYLE="vertical-align: bottom; text-align: right">&nbsp;</TD>
<TD STYLE="vertical-align: bottom; text-align: right">&nbsp;</TD>
<TD STYLE="text-align: center; vertical-align: bottom">&nbsp;</TD>
<TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
<TR>
<TD STYLE="white-space: nowrap; vertical-align: top"><A HREF="tm2518234d1_ex99-3.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.3*</FONT></A></TD>
    <TD>&nbsp;</TD>
<TD STYLE="vertical-align: top"><A HREF="tm2518234d1_ex99-3.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form&nbsp;of
Restricted Share Unit Award Agreement to Mind Medicine (MindMed) Inc. 2025 Equity Incentive Plan.</FONT></A></TD>
<TD STYLE="vertical-align: bottom; text-align: right">&nbsp;</TD>
<TD STYLE="vertical-align: bottom; text-align: right">&nbsp;</TD>
<TD STYLE="text-align: center; vertical-align: bottom">&nbsp;</TD>
<TD STYLE="vertical-align: bottom; text-align: center">&nbsp;</TD></TR>
<TR>
<TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
<TD>&nbsp;</TD>
<TD STYLE="text-align: right">&nbsp;</TD>
<TD STYLE="text-align: right">&nbsp;</TD>
<TD STYLE="text-align: center">&nbsp;</TD>
<TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR>
<TD STYLE="white-space: nowrap; vertical-align: top"><A HREF="https://www.sec.gov/Archives/edgar/data/1813814/000095017023007053/mnmd-ex10_16.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.4</FONT></A></TD>
    <TD>&nbsp;</TD>
<TD STYLE="vertical-align: top"><A HREF="https://www.sec.gov/Archives/edgar/data/1813814/000095017023007053/mnmd-ex10_16.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mind
Medicine (MindMed),&nbsp;Inc. Performance and Restricted Share Unit Plan, as amended on March&nbsp;7, 2023. </FONT></A></TD>
<TD STYLE="vertical-align: bottom; text-align: right"><A HREF="https://www.sec.gov/Archives/edgar/data/1813814/000095017023007053/mnmd-ex10_16.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10-K</FONT></A></TD>
<TD STYLE="vertical-align: bottom; text-align: right"><A HREF="https://www.sec.gov/Archives/edgar/data/1813814/000095017023007053/mnmd-ex10_16.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.16</FONT></A></TD>
<TD STYLE="text-align: center; vertical-align: bottom"><A HREF="https://www.sec.gov/Archives/edgar/data/1813814/000095017023007053/mnmd-ex10_16.htm" STYLE="-sec-extract: exhibit">March&nbsp;9,
2023</A></TD>
<TD STYLE="text-align: center; vertical-align: bottom"><A HREF="https://www.sec.gov/Archives/edgar/data/1813814/000095017023007053/mnmd-ex10_16.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">001-40360</FONT></A></TD></TR>
<TR>
<TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
<TD>&nbsp;</TD>
<TD STYLE="text-align: right">&nbsp;</TD>
<TD STYLE="text-align: right">&nbsp;</TD>
<TD STYLE="text-align: center">&nbsp;</TD>
<TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR>
<TD STYLE="white-space: nowrap; vertical-align: top"><A HREF="https://www.sec.gov/Archives/edgar/data/1813814/000095017022004724/mnmd-ex10_4.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.5</FONT></A></TD>
    <TD>&nbsp;</TD>
<TD STYLE="vertical-align: top"><A HREF="https://www.sec.gov/Archives/edgar/data/1813814/000095017022004724/mnmd-ex10_4.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form&nbsp;of
Restricted Share Unit Award Agreement to Mind Medicine (MindMed) Inc. Performance and Restricted Share Unit Plan. </FONT></A></TD>
<TD STYLE="vertical-align: bottom; text-align: right"><A HREF="https://www.sec.gov/Archives/edgar/data/1813814/000095017022004724/mnmd-ex10_4.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10-K</FONT></A></TD>
<TD STYLE="vertical-align: bottom; text-align: right"><A HREF="https://www.sec.gov/Archives/edgar/data/1813814/000095017022004724/mnmd-ex10_4.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;10.4</FONT></A></TD>
<TD STYLE="text-align: center; vertical-align: bottom"><A HREF="https://www.sec.gov/Archives/edgar/data/1813814/000095017022004724/mnmd-ex10_4.htm" STYLE="-sec-extract: exhibit">March&nbsp;28,&nbsp;2022</A></TD>
<TD STYLE="text-align: center; vertical-align: bottom"><A HREF="https://www.sec.gov/Archives/edgar/data/1813814/000095017022004724/mnmd-ex10_4.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">001-40360</FONT></A></TD></TR>
<TR>
<TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
<TD>&nbsp;</TD>
<TD STYLE="text-align: right">&nbsp;</TD>
<TD STYLE="text-align: right">&nbsp;</TD>
<TD STYLE="text-align: center">&nbsp;</TD>
<TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR>
<TD STYLE="text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/1813814/000095017025066387/mnmd-ex10_1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.6</FONT></A></TD>
    <TD>&nbsp;</TD>
<TD><A HREF="https://www.sec.gov/Archives/edgar/data/1813814/000095017025066387/mnmd-ex10_1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form&nbsp;of
Performance Share Unit Award Agreement to Performance and Restricted Share Unit Plan.</FONT></A></TD>
<TD STYLE="text-align: right"><A HREF="https://www.sec.gov/Archives/edgar/data/1813814/000095017025066387/mnmd-ex10_1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;10-Q</FONT></A></TD>
<TD STYLE="text-align: right"><A HREF="https://www.sec.gov/Archives/edgar/data/1813814/000095017025066387/mnmd-ex10_1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</FONT></A></TD>
<TD STYLE="text-align: center"><A HREF="https://www.sec.gov/Archives/edgar/data/1813814/000095017025066387/mnmd-ex10_1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">May&nbsp;8,
2025</FONT></A></TD>
<TD STYLE="text-align: center"><A HREF="https://www.sec.gov/Archives/edgar/data/1813814/000095017025066387/mnmd-ex10_1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">001-40360</FONT></A></TD></TR>
<TR>
<TD STYLE="text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
<TD>&nbsp;</TD>
<TD STYLE="text-align: right">&nbsp;</TD>
<TD STYLE="text-align: right">&nbsp;</TD>
<TD STYLE="text-align: center">&nbsp;</TD>
<TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR>
<TD STYLE="text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/1813814/000095017025066387/mnmd-ex10_2.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.7</FONT></A></TD>
    <TD>&nbsp;</TD>
<TD><A HREF="https://www.sec.gov/Archives/edgar/data/1813814/000095017025066387/mnmd-ex10_2.htm" STYLE="-sec-extract: exhibit">Form&nbsp;of
Performance Share Unit Award Agreement granted as an Inducement Award. &nbsp;</A></TD>
<TD STYLE="text-align: right"><A HREF="https://www.sec.gov/Archives/edgar/data/1813814/000095017025066387/mnmd-ex10_2.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10-Q</FONT></A></TD>
<TD STYLE="text-align: right"><A HREF="https://www.sec.gov/Archives/edgar/data/1813814/000095017025066387/mnmd-ex10_2.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</FONT></A></TD>
<TD STYLE="text-align: center"><A HREF="https://www.sec.gov/Archives/edgar/data/1813814/000095017025066387/mnmd-ex10_2.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">May&nbsp;8,
2025</FONT></A></TD>
<TD STYLE="text-align: center"><A HREF="https://www.sec.gov/Archives/edgar/data/1813814/000095017025066387/mnmd-ex10_2.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">001-40360</FONT></A></TD></TR>
<TR>
<TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
<TD>&nbsp;</TD>
<TD STYLE="text-align: right">&nbsp;</TD>
<TD STYLE="text-align: right">&nbsp;</TD>
<TD STYLE="text-align: center">&nbsp;</TD>
<TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR>
<TD><A HREF="https://www.sec.gov/Archives/edgar/data/1813814/000095017025066387/mnmd-ex10_3.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.8</FONT></A></TD>
    <TD>&nbsp;</TD>
<TD><A HREF="https://www.sec.gov/Archives/edgar/data/1813814/000095017025066387/mnmd-ex10_3.htm" STYLE="-sec-extract: exhibit">Form&nbsp;of Restricted Share Unit Award Agreement granted as an Inducement Award. &nbsp;</A></TD>
<TD STYLE="text-align: right"><A HREF="https://www.sec.gov/Archives/edgar/data/1813814/000095017025066387/mnmd-ex10_3.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10-Q</FONT></A></TD>
<TD STYLE="text-align: right"><A HREF="https://www.sec.gov/Archives/edgar/data/1813814/000095017025066387/mnmd-ex10_3.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3</FONT></A></TD>
<TD STYLE="text-align: center"><A HREF="https://www.sec.gov/Archives/edgar/data/1813814/000095017025066387/mnmd-ex10_3.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">May&nbsp;8, 2025</FONT></A></TD>
<TD STYLE="text-align: center"><A HREF="https://www.sec.gov/Archives/edgar/data/1813814/000095017025066387/mnmd-ex10_3.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">001-40360</FONT></A></TD></TR>
<TR>
<TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
<TD>&nbsp;</TD>
<TD STYLE="text-align: right">&nbsp;</TD>
<TD STYLE="text-align: right">&nbsp;</TD>
<TD STYLE="text-align: center">&nbsp;</TD>
<TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR>
<TD><A HREF="https://www.sec.gov/Archives/edgar/data/1813814/000095017025066387/mnmd-ex10_4.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.9</FONT></A></TD>
    <TD>&nbsp;</TD>
<TD><A HREF="https://www.sec.gov/Archives/edgar/data/1813814/000095017025066387/mnmd-ex10_4.htm" STYLE="-sec-extract: exhibit">Form&nbsp;of Option Agreement granted as an Inducement Award. &nbsp;</A></TD>
<TD STYLE="text-align: right"><A HREF="https://www.sec.gov/Archives/edgar/data/1813814/000095017025066387/mnmd-ex10_4.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10-Q</FONT></A></TD>
<TD STYLE="text-align: right"><A HREF="https://www.sec.gov/Archives/edgar/data/1813814/000095017025066387/mnmd-ex10_4.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.4</FONT></A></TD>
<TD STYLE="text-align: center"><A HREF="https://www.sec.gov/Archives/edgar/data/1813814/000095017025066387/mnmd-ex10_4.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">May&nbsp;8, 2025</FONT></A></TD>
<TD STYLE="text-align: center"><A HREF="https://www.sec.gov/Archives/edgar/data/1813814/000095017025066387/mnmd-ex10_4.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">001-40360</FONT></A></TD></TR>
<TR>
<TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
<TD>&nbsp;</TD>
<TD STYLE="text-align: right">&nbsp;</TD>
<TD STYLE="text-align: right">&nbsp;</TD>
<TD STYLE="text-align: center">&nbsp;</TD>
<TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR>
<TD STYLE="white-space: nowrap; vertical-align: top"><A HREF="tm2518234d1_ex-filingfees.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">107*</FONT></A></TD>
    <TD>&nbsp;</TD>
<TD STYLE="vertical-align: top"><A HREF="tm2518234d1_ex-filingfees.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filing
Fee Table.</FONT></A></TD>
<TD STYLE="text-align: right; vertical-align: bottom">&nbsp;</TD>
<TD STYLE="text-align: right; vertical-align: bottom">&nbsp;</TD>
<TD STYLE="text-align: center; vertical-align: bottom">&nbsp;</TD>
<TD STYLE="text-align: center; vertical-align: bottom">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 3pt; margin-bottom: 3pt; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>


<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed herewith. </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 10%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ITEM&nbsp;9.</B></FONT></TD>
    <TD STYLE="width: 90%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>UNDERTAKINGS </B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(a)</TD><TD STYLE="text-align: justify">The undersigned Registrant hereby undertakes:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">(1)</TD><TD STYLE="text-align: justify">To file, during any period in which offers or sales are being made, a post-effective amendment to this
registration statement:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.25in"></TD><TD STYLE="width: 0.25in">(i)</TD><TD STYLE="text-align: justify">to include any prospectus required by Section&nbsp;10(a)(3)&nbsp;of the Securities Act;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.25in"></TD><TD STYLE="width: 0.25in">(ii)</TD><TD STYLE="text-align: justify">to reflect in the prospectus any facts or events arising after the effective date of this registration
statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change
in the information set forth in this registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities
offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or
high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule&nbsp;424(b)&nbsp;if,
in the aggregate, the changes in volume and price represent no more than 20% change in the maximum aggregate offering price set forth
in the &ldquo;Calculation of Filing Fee Tables&rdquo; or &ldquo;Calculation of Registration Fee&rdquo; table, as applicable, in the effective
registration statement; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.25in"></TD><TD STYLE="width: 0.25in">(iii)</TD><TD STYLE="text-align: justify">to include any material information with respect to the plan of distribution not previously disclosed
in the registration statement or any material change to such information in the registration statement;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>provided, however</I>, that paragraphs (a)(1)(i)&nbsp;and
(a)(1)(ii)&nbsp;of this section do not apply if the information required to be included in a post-effective amendment by those paragraphs
is contained in reports filed with or furnished to the Commission by the Registrant pursuant to Section&nbsp;13 or 15(d)&nbsp;of the Exchange
Act that are incorporated by reference in this registration statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">(2)</TD><TD STYLE="text-align: justify">That, for the purpose of determining any liability under the Securities Act, each such post-effective
amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities
at that time shall be deemed to be the initial <I>bona fide</I> offering thereof.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">(3)</TD><TD STYLE="text-align: justify">To remove from registration by means of a post-effective amendment any of the securities being registered
which remain unsold at the termination of the offering.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(b)</TD><TD STYLE="text-align: justify">The undersigned Registrant hereby undertakes that, for purposes of determining any liability under the
Securities Act, each filing of the Registrant&rsquo;s annual report pursuant to Section&nbsp;13(a)&nbsp;or 15(d)&nbsp;of the Exchange
Act (and, where applicable, each filing of an employee benefit plan&rsquo;s annual report pursuant to Section&nbsp;15(d)&nbsp;of the Exchange
Act) that is incorporated by reference in this registration statement shall be deemed to be a new registration statement relating to the
securities offered therein, and the offering of such securities at that time shall be deemed to be the initial <I>bona fide</I> offering
thereof.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(c)</TD><TD STYLE="text-align: justify">Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors,
officers and controlling persons of the Registrant pursuant to the foregoing provisions, or otherwise, the Registrant has been advised
that in the opinion of the Commission such indemnification is against public policy as expressed in the Securities Act and is, therefore,
unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the Registrant of expenses
incurred or paid by a director, officer or controlling person of the Registrant in the successful defense of any action, suit or proceeding)
is asserted by such director, officer or controlling person in connection with the securities being registered, the Registrant will, unless
in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the
question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final
adjudication of such issue.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SIGNATURES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Pursuant to the requirements
of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements
for filing on Form&nbsp;S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly
authorized, in the City of New York, State of New York, on June&nbsp;20, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 47%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Mind Medicine (MindMed) Inc.</B></FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Robert Barrow</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Robert Barrow</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Chief Executive Officer</I></FONT></TD></TR>
  </TABLE>
<P STYLE="text-indent: 0.25in; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_001"></A>POWER OF ATTORNEY</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">KNOW ALL BY THESE PRESENTS,
that each person whose signature appears below hereby constitutes and appoints Robert Barrow and Mark R. Sullivan, and each of them, his
or her true and lawful agents, proxies and attorneys-in-fact, with full power of substitution and resubstitution, for and in his or her
name, place and stead, in any and all capacities, to sign any and all amendments (including post-effective amendments) to this Registration
Statement, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange
Commission, granting unto said attorneys-in-fact full power and authority to do and perform each and every act and thing requisite and
necessary to be done as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all
that said attorneys-in-fact may lawfully do or cause to be done by virtue hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Pursuant to the requirements of the Securities
Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; border-bottom: black 1pt solid; width: 30%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Signature</B></FONT></TD>
    <TD STYLE="padding-bottom: 1pt; vertical-align: top; width: 2%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Title</B></FONT></TD>
    <TD STYLE="padding-bottom: 1pt; vertical-align: top; width: 2%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid; width: 16%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Date</B></FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="border-bottom: Black 1pt solid; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Robert Barrow </FONT></TD>
    <TD ROWSPAN="2" STYLE="vertical-align: top">&nbsp;</TD>
    <TD ROWSPAN="2" STYLE="vertical-align: top"><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer and Director</FONT></P>
                                                <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<I>Principal Executive Officer</I>)</FONT></P></TD>
    <TD ROWSPAN="2" STYLE="vertical-align: top">&nbsp;</TD>
    <TD ROWSPAN="2" STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">June&nbsp;20,
2025</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Robert Barrow</B></FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="border-bottom: Black 1pt solid; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Brandi L. Roberts</FONT></TD>
    <TD ROWSPAN="2" STYLE="vertical-align: top">&nbsp;</TD>
    <TD ROWSPAN="2" STYLE="vertical-align: top"><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Financial Officer</FONT></P>
                                                <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<I>Principal Financial Officer and Principal Accounting Officer</I>)</FONT></P></TD>
    <TD ROWSPAN="2" STYLE="vertical-align: top">&nbsp;</TD>
    <TD ROWSPAN="2" STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">June&nbsp;20,
2025</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Brandi L. Roberts</B></FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="border-bottom: Black 1pt solid; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Suzanne Bruhn </FONT></TD>
    <TD ROWSPAN="2" STYLE="vertical-align: top">&nbsp;</TD>
    <TD ROWSPAN="2" STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD ROWSPAN="2" STYLE="vertical-align: top">&nbsp;</TD>
    <TD ROWSPAN="2" STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">June&nbsp;20,
2025</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Suzanne Bruhn, PhD</B></FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="border-bottom: Black 1pt solid; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ David Gryska </FONT></TD>
    <TD ROWSPAN="2" STYLE="vertical-align: top">&nbsp;</TD>
    <TD ROWSPAN="2" STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD ROWSPAN="2" STYLE="vertical-align: top">&nbsp;</TD>
    <TD ROWSPAN="2" STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">June&nbsp;20,
2025</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>David Gryska</B></FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="border-bottom: Black 1pt solid; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Roger Crystal </FONT></TD>
    <TD ROWSPAN="2" STYLE="vertical-align: top">&nbsp;</TD>
    <TD ROWSPAN="2" STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD ROWSPAN="2" STYLE="vertical-align: top">&nbsp;</TD>
    <TD ROWSPAN="2" STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">June&nbsp;20,
2025</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Roger Crystal, MD</B></FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="border-bottom: Black 1pt solid; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Andreas Krebs </FONT></TD>
    <TD ROWSPAN="2" STYLE="vertical-align: top">&nbsp;</TD>
    <TD ROWSPAN="2" STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD ROWSPAN="2" STYLE="vertical-align: top">&nbsp;</TD>
    <TD ROWSPAN="2" STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">June&nbsp;20,
2025</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Andreas Krebs</B></FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="border-bottom: Black 1pt solid; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Carol A. Vallone </FONT></TD>
    <TD ROWSPAN="2" STYLE="vertical-align: top">&nbsp;</TD>
    <TD ROWSPAN="2" STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD ROWSPAN="2" STYLE="vertical-align: top">&nbsp;</TD>
    <TD ROWSPAN="2" STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">June&nbsp;20,
2025</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Carol A. Vallone</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SIGNATURE OF AUTHORIZED U.S. REPRESENTATIVE
OF THE REGISTRANT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Pursuant to the requirements of Section&nbsp;6(a)&nbsp;of
the Securities Act of 1933, as amended, the undersigned has signed this Registration Statement, solely in its capacity as duly authorized
representative of Mind Medicine (MindMed) Inc. in the United States, on the 20<SUP>th</SUP> day of June, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 3%; border-bottom: black 1pt solid; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 47%; border-bottom: black 1pt solid; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Mark R. Sullivan</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mark R. Sullivan</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Legal Officer&nbsp;&amp; Corporate Secretary</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 10; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
[{"type": "S-8", "sequence": "1", "filename": "tm2518234d1_s8.htm", "description": "FORM S-8", "secsgml_size_bytes": 100046}]
{"company-data": {"conformed-name": "Mind Medicine (MindMed) Inc.", "cik": "0001813814", "assigned-sic": "2833", "organization-name": "03 Life Sciences", "ein": "000000000", "state-of-incorporation": "A1", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-8", "act": "33", "file-number": "333-288186", "film-number": "251061350"}, "business-address": {"street1": "ONE WORLD TRADE CENTER", "street2": "SUITE 8500", "city": "NEW YORK", "state": "NY", "zip": "10007", "phone": "212-220-6633"}, "mail-address": {"street1": "ONE WORLD TRADE CENTER", "street2": "SUITE 8500", "city": "NEW YORK", "state": "NY", "zip": "10007"}}
As filed with the Securities and Exchange Commission
on June 20, 2025
Registration No. 333-
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM S-8
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
MIND MEDICINE (MINDMED) INC.
(Exact name of registrant as specified in its
charter)
British Columbia, Canada
(State or other jurisdiction of
incorporation or organization)
98-1582438
(I.R.S. Employer
Identification Number)
One World Trade Center, Suite 8500
New York, New York
(212) 220-6633
(Address of Principal Executive Offices)
10007
(Zip Code)
MIND MEDICINE (MINDMED) INC. 2025 EQUITY
INCENTIVE PLAN
MIND MEDICINE (MINDMED) INC. PERFORMANCE AND
RESTRICTED SHARE UNIT PLAN
INDIVIDUAL NONSTATUTORY STOCK OPTION AWARDS
(INDUCEMENT GRANTS)
INDIVIDUAL RESTRICTED SHARE UNIT AWARDS (INDUCEMENT
GRANTS)
INDIVIDUAL PERFORMANCE SHARE UNIT AWARDS (INDUCEMENT
GRANTS)
(Full titles of the plans)
Mark Sullivan
Chief Legal Officer
Mind Medicine (MindMed) Inc.
One World Trade Center
Suite 8500
New York, New York 10007
(Name and address of agent for service)
(212) 220-6633
(Telephone number, including area code, of agent
for service)
Copies to:
Steven J. Abrams
Hogan Lovells US LLP
1735 Market Street
Suite 2300
Philadelphia, Pennsylvania 19103
(267) 675-4600
Trevor Scott
Minji Park
Osler, Hoskin & Harcourt LLP
Suite 3000, Bentall Four
1055 Dunsmuir Street
Vancouver, British Columbia, Canada V7X 1K8
(778) 785-3000
Indicate by check mark whether the registrant is a large accelerated
filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of
 "large accelerated filer," "accelerated filer," "smaller reporting company" and "emerging growth
company" in Rule 12b-2 of the Exchange Act.
Large accelerated filer
¨
Accelerated filer
¨
Non-accelerated filer
x
Smaller reporting company
x
Emerging growth company
x
If an emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant
to Section 7(a)(2)(B) of the Securities Act.
¨
EXPLANATORY NOTE
Mind Medicine (MindMed) Inc. 2025 Equity Incentive
Plan
This registration statement
on Form S-8 (this "
Registration Statement
") is being filed by Mind Medicine (MindMed) Inc. (the "
Registrant
"),
to register an aggregate of 13,818,090 common shares, no par value per share, of the Registrant (the "
Common Shares
"),
issuable under the Mind Medicine (MindMed) Inc. 2025 Equity Incentive Plan (the "
2025 Plan
"), consisting of
(a) 4,500,000 Common Shares reserved for issuance under the 2025 Plan, and (b) a maximum of 9,318,090 Common Shares (the "
Outstanding
Award Shares
") consisting of (i) an aggregate of 3,500,979 Common Shares that were subject to outstanding option awards
under the Mind Medicine (MindMed) Inc. Stock Option Plan, as amended (the "
Option Plan
"), and (ii) an aggregate
of 5,817,111 Common Shares subject to outstanding restricted share unit awards and performance share unit awards under the Mind Medicine
(MindMed) Inc. Performance and Restricted Share Unit Plan, as amended (the "
PRSU Plan
" and, together with the
Option Plan, the "
Prior Plans
"), as of March 14, 2025, the date the Prior Plans were retired. Pursuant
to Section 4.1 of the 2025 Plan, the Outstanding Award Shares will become available for issuance under the 2025 Plan if such awards
under the Prior Plans are forfeited or otherwise terminated. The Board of Directors of the Registrant approved the 2025 Plan on April 22,
2025, and the Registrant's shareholders approved the 2025 Plan at the Registrant's 2025 Annual General and Special Meeting
of Shareholders on June 12, 2025.
Mind Medicine (MindMed)
Inc. Performance and Restricted Share Unit Plan
This Registration Statement
is also being filed to register 147,133 Common Shares, issuable under the PRSU Plan.
Inducement Grants
This Registration Statement
is also being filed to register an aggregate of 2,402,550 Common Shares issuable upon the exercise of individual nonqualified stock option
awards and upon vesting and settlement of restricted share units and performance share units granted to employees of the Registrant as
an inducement material to entry into employment with the Registrant, in accordance with Nasdaq Listing Rule 5635(c)(4).
PART I
INFORMATION REQUIRED IN THE SECTION 10(A) PROSPECTUS
As permitted by the rules of
the Securities and Exchange Commission (the "
Commission
"), the information specified in Part I of Form S-8
is omitted from this Registration Statement. The documents containing the information specified in Part I of Form S-8 will be
delivered to the participants in the plans covered by this Registration Statement as required by Rule 428(b)(1) under the Securities
Act of 1933, as amended (the "
Securities Act
").
PART II
INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
ITEM 3.
INCORPORATION OF DOCUMENTS BY REFERENCE
The following documents filed
by the Registrant with the Commission are incorporated by reference into this Registration Statement:
a)
The Registrant's Annual Report
                                            on
Form 10-K
for the fiscal year ended December 31, 2024, filed with the Commission
                                            on March 6, 2025, including portions of the Registrant's Definitive Proxy Statement
                                            on
Schedule 14A
, filed with the Commission on April 23, 2025, that are incorporated
                                            by reference into Part III of such Annual Report on Form 10-K;
b)
The Registrant's Quarterly Report
                                            on
Form 10-Q
for the quarterly period ended March 31, 2025, filed with the Commission
                                            on May 8, 2025;
c)
The Registrant's Current Reports on Form 8-K (other than portions thereof furnished under Item
2.02 or Item 7.01 of Form 8-K and exhibits accompanying such reports that relate to such items), filed with the Commission on
January 13, 2025
,
January 30, 2025
,
April 15, 2025
,
April 21, 2025
,
May 27, 2025
and
June 16, 2025
; and
d)
The description of the Registrant's common shares which is contained in the Registrant's Registration
Statement on
Form 8-A
, filed with the Commission on April 22, 2021 (File No 001-40360) under
the Securities Exchange Act of 1934, as amended (the "
Exchange Act
"), as updated by
Exhibit 4.1
to
the Registrant's Annual Report on Form 10-K for the fiscal year ended December 31, 2024, filed with the Commission
on March 6, 2025, including any amendment or report filed for the purpose of updating such description.
All documents subsequently
filed by the Registrant pursuant to Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act after the date of this Registration Statement
and prior to the filing of a post-effective amendment to this Registration Statement which indicates that all securities offered have
been sold or which deregisters all securities then remaining unsold, shall be deemed to be incorporated by reference into this Registration
Statement and to be part hereof from the date of filing of such documents; provided, however, that documents or portions thereof that
are furnished and not filed in accordance with the rules of the Commission shall not be deemed incorporated by reference into this
Registration Statement.
Any statement in a document
incorporated or deemed to be incorporated by reference into this Registration Statement shall be deemed to be modified or superseded for
purposes of this Registration Statement to the extent that a statement contained in this Registration Statement or in any other later
filed document that also is or is deemed to be incorporated by reference into this Registration Statement modifies or supersedes such
statement. Any such statement so modified or superseded shall not be deemed, except as so modified or superseded, to be a part of this
Registration Statement.
ITEM 4.
DESCRIPTION OF SECURITIES
Not applicable.
ITEM 5.
INTERESTS OF NAMED EXPERTS AND COUNSEL
Not applicable.
ITEM 6.
INDEMNIFICATION OF DIRECTORS AND OFFICERS
The Registrant is subject
to the provisions of Part 5, Division 5 of the Business Corporations Act (
British Columbia
) (the "
Act
"),
and the indemnification provisions set forth in the Registrant's amended and restated articles (the "
Articles
").
The Registrant has also entered into indemnity agreements with each of its directors and executive officers which provide its directors
and executive officers with contractual rights to indemnification and, in some cases, expenses advancement in any action or proceedings
arising out of their services as one of its directors or executive officers or as a director or executive officer of any other company
or enterprise to which the person provides services at the Registrant's request.
Under the Registrant's
Articles and Section 160 of the Act, subject to Section 163 of the Act, the Registrant may:
a)
indemnify an individual who:
i.
is or was a director or officer of the Registrant,
ii.
is or was a director or officer of another corporation (A) at a time when such corporation is or
was an affiliate of the Registrant; or (B) at the Registrant's request, or
iii.
at the Registrant's request, is or was, or holds or held a position equivalent to that of, a director
or officer of a partnership, trust, joint venture or other unincorporated entity,
including, subject to certain limited
exceptions, the heirs and personal or other legal representatives of that individual (collectively, an "
eligible party
"),
against all eligible penalties, as defined below, to which the eligible party is or may be liable; and
b)
after final disposition of an eligible proceeding, pay the expenses actually and reasonably incurred by
an eligible party in respect of that proceeding, where:
i.
"
eligible penalty
" means a judgment, penalty or fine awarded or imposed in,
or an amount paid in settlement of, an eligible proceeding,
ii.
"
eligible proceeding
" means a proceeding in which an eligible party or any of
the heirs and personal or other legal representatives of the eligible party, by reason of the eligible party being or having been a director
or officer of, or holding or having held a position equivalent to that of a director or officer of, the Registrant or an associated corporation
(A) is or may be joined as a party, or (B) is or may be liable for or in respect of a judgment, penalty or fine in, or expenses
related to, the proceeding,
iii.
"
expenses
" includes costs, charges and expenses, including legal and other fees,
but does not include judgments, penalties, fines or amounts paid in settlement of a proceeding, and
iv.
"
proceeding
" includes any legal proceeding or investigative action, whether
current, threatened, pending or completed.
Under the Registrant's
Articles, the Registrant may also indemnify any employee, agent or representative of the Registrant, subject to any restrictions under
the Act.
Under the Registrant's
Articles and Section 161 of the Act, and subject to Section 163 of the Act, the Registrant must, after the final disposition
of an eligible proceeding, pay the expenses actually and reasonably incurred by an eligible party in respect of that proceeding if the
eligible party (a) has not been reimbursed for those expenses, and (b) is wholly successful, on the merits or otherwise, in
the outcome of the proceeding or is substantially successful on the merits in the outcome of the proceeding.
Under Section 162 of
the Act, and subject to Section 163 of the Act, the Registrant may pay, as they are incurred in advance of the final disposition
of an eligible proceeding, the expenses actually and reasonably incurred by an eligible party in respect of the proceeding, provided that
the Registrant must not make such payments unless the Registrant first receives from the eligible party a written undertaking that, if
it is ultimately determined that the payment of expenses is prohibited under Section 163 of the Act, the eligible party will repay
the amounts advanced.
Under Section 163 of
the Act, the Registrant must not indemnify an eligible party against eligible penalties to which the eligible party is or may be liable
or pay the expenses of an eligible party in respect of that proceeding under Sections 160, 161 or 162 of the Act, as the case may
be, if any of the following circumstances apply:
a)
if the indemnity or payment is made under an earlier agreement to indemnify or pay expenses and, at the
time that the agreement to indemnify or pay expenses was made, the Registrant was prohibited from giving the indemnity or paying the expenses
by the Registrant's memorandum or articles;
b)
if the indemnity or payment is made otherwise than under an earlier agreement to indemnify or pay expenses
and, at the time that the indemnity or payment is made, the Registrant is prohibited from giving the indemnity or paying the expenses
by the Registrant's memorandum or articles;
c)
if, in relation to the subject matter of the eligible proceeding, the eligible party did not act honestly
and in good faith with a view to the best interests of the Registrant or the associated corporation, as the case may be; or
d)
in the case of an eligible proceeding other than a civil proceeding, if the eligible party did not have
reasonable grounds for believing that the eligible party's conduct in respect of which the proceeding was brought was lawful.
If an eligible proceeding
is brought against an eligible party by or on behalf of the Registrant or by or on behalf of an associated corporation, the Registrant
must not either indemnify the eligible party under Section 160(a) of the Act against eligible penalties to which the eligible
party is or may be liable, or pay the expenses of the eligible party under Sections 160(b), 161 or 162 of the Act, as the case may
be, in respect of the proceeding.
Under Section 164 of
the Act, and despite any other provision of Part 5, Division 5 of the Act and whether or not payment of expenses or indemnification
has been sought, authorized or declined under Part 5, Division 5 of the Act, on application of the Registrant or an eligible party,
the court may do one or more of the following:
a)
order the Registrant to indemnify an eligible party against any liability incurred by the eligible party
in respect of an eligible proceeding;
b)
order the Registrant to pay some or all of the expenses incurred by an eligible party in respect of an
eligible proceeding;
c)
order the enforcement of, or any payment under, an agreement of indemnification entered into by the Registrant;
d)
order the Registrant to pay some or all of the expenses actually and reasonably incurred by any person
in obtaining an order under Section 164 of the Act; or
e)
make any other order the court considers appropriate.
Section 165 of the Act
provides that the Registrant may purchase and maintain insurance for the benefit of an eligible party or the heirs and personal or other
legal representatives of the eligible party against any liability that may be incurred by reason of the eligible party being or having
been a director or officer of, or holding or having held a position equivalent to that of a director or officer of, the Registrant or
an associated corporation. Under the Registrant's Articles, the Registrant may also purchase and maintain insurance for the benefit
of any person (or his or her heirs or legal personal representatives) who:
a)
is or was a director, officer, employee or agent of the Registrant;
b)
is or was a director, officer, employee or agent of another corporation at a time when such corporation
is or was an affiliate of the Registrant;
c)
at the Registrant's request, is or was, a director, officer, employee or agent of a corporation
or of a partnership, trust, joint venture or other unincorporated entity; and
d)
at the Registrant's request, holds or held a position equivalent to that of, a director or officer
of a partnership, trust, joint venture or other unincorporated entity,
against any liability incurred
by him or her as such director, officer, employee or agent or person who holds or held such equivalent position.
The Registrant maintains
directors' and officers' liability insurance which insures directors and officers for losses as a result of claims against
the directors and officers of the Registrant in their capacity as directors and officers.
Pursuant to the Registrant's
Articles, the failure of a director or officer of the Registrant to comply with the Act or the Registrant's Articles does not invalidate
any indemnity to which he or she is entitled under the Registrant's Articles.
Insofar as indemnification
for liabilities arising under the Securities Act may be permitted to directors, officers or persons controlling the Registrant pursuant
to the foregoing provisions, the Registrant has been informed that in the opinion of the Commission such indemnification is against public
policy as expressed in the Securities Act and is therefore unenforceable.
ITEM 7.
EXEMPTION FROM REGISTRATION CLAIMED
Not applicable.
ITEM 8.
EXHIBITS
Exhibit
Number
Description
Form
Exhibit No.
Incorporated by
Reference Filing
Date
File No.
4.1
Amended and Restated Articles of Mind Medicine (MindMed) Inc., effective as of June 30, 2022.
8-K
3.1
June 30, 2022
001-40360
4.2
Notice of Articles, Incorporated on July 26, 2010, as altered on July 30, 2024.
10-Q
3.2
August 13, 2024
001-40360
4.3
Form of
Mind Medicine (MindMed) Inc. Common Share Certificate.
10-K
4.2
February 28,
2024
001-40360
5.1*
Opinion of Osler, Hoskin &
Harcourt LLP.
23.1*
Consent
of KPMG LLP.
23.2*
Consent of Osler, Hoskin &
Harcourt LLP (included in Exhibit 5.1).
24.1*
Powers of Attorney (included
on the signature page).
99.1
Mind
Medicine (MindMed) Inc. 2025 Equity Incentive Plan.
8-K
10.1
June 16,
2025
001-40360
99.2*
Form of
Stock Option Award Agreement to Mind Medicine (MindMed) Inc. 2025 Equity Incentive Plan.
99.3*
Form of
Restricted Share Unit Award Agreement to Mind Medicine (MindMed) Inc. 2025 Equity Incentive Plan.
99.4
Mind
Medicine (MindMed), Inc. Performance and Restricted Share Unit Plan, as amended on March 7, 2023.
10-K
10.16
March 9,
2023
001-40360
99.5
Form of
Restricted Share Unit Award Agreement to Mind Medicine (MindMed) Inc. Performance and Restricted Share Unit Plan.
10-K
10.4
March 28, 2022
001-40360
99.6
Form of
Performance Share Unit Award Agreement to Performance and Restricted Share Unit Plan.
10-Q
10.1
May 8,
2025
001-40360
99.7
Form of
Performance Share Unit Award Agreement granted as an Inducement Award.
10-Q
10.2
May 8,
2025
001-40360
99.8
Form of Restricted Share Unit Award Agreement granted as an Inducement Award.
10-Q
10.3
May 8, 2025
001-40360
99.9
Form of Option Agreement granted as an Inducement Award.
10-Q
10.4
May 8, 2025
001-40360
107*
Filing
Fee Table.
*
Filed herewith.
ITEM 9.
UNDERTAKINGS
(a)
The undersigned Registrant hereby undertakes:
(1)
To file, during any period in which offers or sales are being made, a post-effective amendment to this
registration statement:
(i)
to include any prospectus required by Section 10(a)(3) of the Securities Act;
(ii)
to reflect in the prospectus any facts or events arising after the effective date of this registration
statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change
in the information set forth in this registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities
offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or
high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if,
in the aggregate, the changes in volume and price represent no more than 20% change in the maximum aggregate offering price set forth
in the "Calculation of Filing Fee Tables" or "Calculation of Registration Fee" table, as applicable, in the effective
registration statement; and
(iii)
to include any material information with respect to the plan of distribution not previously disclosed
in the registration statement or any material change to such information in the registration statement;
provided, however
, that paragraphs (a)(1)(i) and
(a)(1)(ii) of this section do not apply if the information required to be included in a post-effective amendment by those paragraphs
is contained in reports filed with or furnished to the Commission by the Registrant pursuant to Section 13 or 15(d) of the Exchange
Act that are incorporated by reference in this registration statement.
(2)
That, for the purpose of determining any liability under the Securities Act, each such post-effective
amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities
at that time shall be deemed to be the initial
bona fide
offering thereof.
(3)
To remove from registration by means of a post-effective amendment any of the securities being registered
which remain unsold at the termination of the offering.
(b)
The undersigned Registrant hereby undertakes that, for purposes of determining any liability under the
Securities Act, each filing of the Registrant's annual report pursuant to Section 13(a) or 15(d) of the Exchange
Act (and, where applicable, each filing of an employee benefit plan's annual report pursuant to Section 15(d) of the Exchange
Act) that is incorporated by reference in this registration statement shall be deemed to be a new registration statement relating to the
securities offered therein, and the offering of such securities at that time shall be deemed to be the initial
bona fide
offering
thereof.
(c)
Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors,
officers and controlling persons of the Registrant pursuant to the foregoing provisions, or otherwise, the Registrant has been advised
that in the opinion of the Commission such indemnification is against public policy as expressed in the Securities Act and is, therefore,
unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the Registrant of expenses
incurred or paid by a director, officer or controlling person of the Registrant in the successful defense of any action, suit or proceeding)
is asserted by such director, officer or controlling person in connection with the securities being registered, the Registrant will, unless
in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the
question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final
adjudication of such issue.
SIGNATURES
Pursuant to the requirements
of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements
for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly
authorized, in the City of New York, State of New York, on June 20, 2025.
Mind Medicine (MindMed) Inc.
By:
/s/ Robert Barrow
Robert Barrow
Chief Executive Officer
POWER OF ATTORNEY
KNOW ALL BY THESE PRESENTS,
that each person whose signature appears below hereby constitutes and appoints Robert Barrow and Mark R. Sullivan, and each of them, his
or her true and lawful agents, proxies and attorneys-in-fact, with full power of substitution and resubstitution, for and in his or her
name, place and stead, in any and all capacities, to sign any and all amendments (including post-effective amendments) to this Registration
Statement, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange
Commission, granting unto said attorneys-in-fact full power and authority to do and perform each and every act and thing requisite and
necessary to be done as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all
that said attorneys-in-fact may lawfully do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities
Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
Signature
Title
Date
/s/ Robert Barrow
Chief Executive Officer and Director
(
Principal Executive Officer
)
June 20,
2025
Robert Barrow
/s/ Brandi L. Roberts
Chief Financial Officer
(
Principal Financial Officer and Principal Accounting Officer
)
June 20,
2025
Brandi L. Roberts
/s/ Suzanne Bruhn
Director
June 20,
2025
Suzanne Bruhn, PhD
/s/ David Gryska
Director
June 20,
2025
David Gryska
/s/ Roger Crystal
Director
June 20,
2025
Roger Crystal, MD
/s/ Andreas Krebs
Director
June 20,
2025
Andreas Krebs
/s/ Carol A. Vallone
Director
June 20,
2025
Carol A. Vallone
SIGNATURE OF AUTHORIZED U.S. REPRESENTATIVE
OF THE REGISTRANT
Pursuant to the requirements of Section 6(a) of
the Securities Act of 1933, as amended, the undersigned has signed this Registration Statement, solely in its capacity as duly authorized
representative of Mind Medicine (MindMed) Inc. in the United States, on the 20
th
day of June, 2025.
/s/ Mark R. Sullivan
Mark R. Sullivan
Chief Legal Officer & Corporate Secretary